What is Zacks Research’s Forecast for CME Group Q4 Earnings?

CME Group Inc. (NASDAQ:CME) – Stock analysts at Zacks Research boosted their Q4 2025 earnings estimates for CME Group in a research report issued to clients and investors on Thursday, April 10th. Zacks Research analyst T. De now forecasts that the financial services provider will post earnings of $2.63 per share for the quarter, up from their previous estimate of $2.53. The consensus estimate for CME Group’s current full-year earnings is $10.49 per share. Zacks Research also issued estimates for CME Group’s Q4 2026 earnings at $2.87 EPS.

A number of other equities analysts have also weighed in on the company. Piper Sandler boosted their target price on CME Group from $275.00 to $283.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 8th. Erste Group Bank raised shares of CME Group to a “strong-buy” rating in a report on Monday, March 17th. Royal Bank of Canada restated a “sector perform” rating and issued a $269.00 target price on shares of CME Group in a report on Thursday, April 3rd. Bank of America boosted their target price on shares of CME Group from $200.00 to $219.00 and gave the company an “underperform” rating in a research note on Wednesday, April 2nd. Finally, Keefe, Bruyette & Woods increased their price target on CME Group from $256.00 to $257.00 and gave the company a “market perform” rating in a report on Friday, February 14th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, four have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, CME Group has a consensus rating of “Hold” and a consensus price target of $247.47.

CME Group Trading Up 0.8 %

Shares of NASDAQ:CME opened at $263.69 on Monday. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. CME Group has a 1 year low of $190.70 and a 1 year high of $273.42. The company has a market cap of $95.02 billion, a P/E ratio of 27.27, a PEG ratio of 6.76 and a beta of 0.43. The stock’s fifty day moving average price is $255.66 and its 200-day moving average price is $239.56.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%.

CME Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th were paid a $1.25 dividend. This is an increase from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date of this dividend was Friday, March 7th. This represents a $5.00 dividend on an annualized basis and a yield of 1.90%. CME Group’s payout ratio is presently 51.71%.

Insider Transactions at CME Group

In other CME Group news, insider Hilda Harris Piell sold 3,984 shares of the business’s stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $250.47, for a total transaction of $997,872.48. Following the sale, the insider now directly owns 27,046 shares of the company’s stock, valued at $6,774,211.62. The trade was a 12.84 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Suzanne Sprague sold 1,500 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $256.83, for a total value of $385,245.00. Following the completion of the sale, the chief operating officer now directly owns 8,036 shares of the company’s stock, valued at $2,063,885.88. The trade was a 15.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 27,076 shares of company stock valued at $6,871,496 in the last ninety days. Corporate insiders own 0.30% of the company’s stock.

Institutional Trading of CME Group

A number of institutional investors have recently bought and sold shares of the stock. SJS Investment Consulting Inc. raised its stake in shares of CME Group by 570.6% in the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 97 shares during the period. New Age Alpha Advisors LLC lifted its stake in CME Group by 50.0% in the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 43 shares during the last quarter. Financial Life Planners purchased a new position in shares of CME Group during the fourth quarter valued at approximately $32,000. Knuff & Co LLC purchased a new stake in shares of CME Group in the fourth quarter worth approximately $33,000. Finally, Fortitude Family Office LLC lifted its stake in shares of CME Group by 120.3% during the 4th quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock worth $35,000 after acquiring an additional 83 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.